Cell-cycle analysis performed by flow cytometry after treatment with ionizing radiation alone or in combination (6 hours before) with tumor necrosis factor–related apoptosis-inducing ligand (1 μg/mL). Analysis was performed 24 hours after irradiation
. | HEL . | K562 . | Friend . | Erythroleukemic blasts . | Normal erythroblasts . | |||||
---|---|---|---|---|---|---|---|---|---|---|
G1 . | S/G2-M . | G1 . | S/G2-M . | G1 . | S/G2-M . | G1 . | S/G2-M . | G1 . | S/G2-M . | |
Control | 65 | 35 | 58 | 42 | 57 | 43 | 58 | 42 | 54 | 46 |
1.5 Gy | 37 | 63 | 39 | 61 | 45 | 55 | 46 | 54 | 44 | 56 |
15 Gy | 17 | 83 | 33 | 67 | 34 | 66 | 33 | 67 | 42 | 58 |
TRAIL | 57 | 43 | 58 | 42 | 55 | 45 | 54 | 46 | 53 | 47 |
1.5 Gy before TRAIL | 38 | 62 | 39 | 61 | 44 | 56 | 45 | 55 | 43 | 57 |
15 Gy before TRAIL | 15 | 85 | 30 | 70 | 35 | 65 | 36 | 64 | 40 | 60 |
. | HEL . | K562 . | Friend . | Erythroleukemic blasts . | Normal erythroblasts . | |||||
---|---|---|---|---|---|---|---|---|---|---|
G1 . | S/G2-M . | G1 . | S/G2-M . | G1 . | S/G2-M . | G1 . | S/G2-M . | G1 . | S/G2-M . | |
Control | 65 | 35 | 58 | 42 | 57 | 43 | 58 | 42 | 54 | 46 |
1.5 Gy | 37 | 63 | 39 | 61 | 45 | 55 | 46 | 54 | 44 | 56 |
15 Gy | 17 | 83 | 33 | 67 | 34 | 66 | 33 | 67 | 42 | 58 |
TRAIL | 57 | 43 | 58 | 42 | 55 | 45 | 54 | 46 | 53 | 47 |
1.5 Gy before TRAIL | 38 | 62 | 39 | 61 | 44 | 56 | 45 | 55 | 43 | 57 |
15 Gy before TRAIL | 15 | 85 | 30 | 70 | 35 | 65 | 36 | 64 | 40 | 60 |
Data represent the means of 2 (erythroleukemic blasts), 4 (HEL, K562, and Friend cell lines) and 5 (normal erythroblasts) separate experiments, performed in duplicate. Fourteen percent of the observations fell within one SD of the means.
TRAIL indicates tumor necrosis factor–related apoptosis-inducing ligand.